Literature DB >> 19321702

Regulation of GLUT4 expression in denervated skeletal muscle.

Ellis B Jensen1, Donghai Zheng, Robert A Russell, Rhonda Bassel-Duby, R Sanders Williams, Ann Louise Olson, G Lynis Dohm.   

Abstract

Denervation by sciatic nerve resection causes decreased muscle glucose transporter 4 (GLUT4) expression, but little is known about the signaling events that cause this decrease. Experiments were designed to test the hypothesis that decreased GLUT4 expression in denervated muscle occurs because of decreased calcium/CaMK activity, which would then lead to decreased activation of the transcription factors myocyte enhancer factor 2 (MEF2) and GLUT4 enhancer factor (GEF), which are required for normal GLUT4 expression. GLUT4 mRNA was elevated in mice expressing constitutively active CaMK isoform IV (CaMKIV) and decreased by denervation. Denervation decreased GEF binding to the promoter and the content of GEF in the nucleus, but there was no change in either MEF2 binding or MEF2 protein content. Expression of a MEF2-dependent reporter gene did not change in denervated skeletal muscle. To determine the domains of the GLUT4 promoter that respond to denervation, transgenic mice expressing the chloramphenicol acetyl transferase (CAT) reporter gene driven by different lengths of the human GLUT4 promoter were denervated. Using several different promoter/reporter gene constructs, we found that all areas of the GLUT4 promoter were truncated or missing, except for the MEF2 binding domain and the basal promoter. All of the GLUT4 promoter/CAT reporter constructs evaluated responded normally to denervation. Our data lead us to conclude that decreased CaMK activity is not the reason for decreased GLUT4 content in denervated muscle and that negative control of GLUT4 expression is not mediated through the MEF2 or GEF-binding domains. These findings indicate that withdrawal of a GEF- or MEF2-dependent signal is not likely a major determinant of the denervation effect on GLUT4 expression. Thus, the response to denervation may be mediated by other elements present in the basal promoter of the GLUT4 gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321702      PMCID: PMC2692789          DOI: 10.1152/ajpregu.90651.2008

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  48 in total

1.  MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type.

Authors:  H Wu; F J Naya; T A McKinsey; B Mercer; J M Shelton; E R Chin; A R Simard; R N Michel; R Bassel-Duby; E N Olson; R S Williams
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  Alteration in the expression of GLUT-1 and GLUT-4 protein and messenger RNA levels in denervated rat muscles.

Authors:  L Coderre; M M Monfar; K S Chen; S J Heydrick; T G Kurowski; N B Ruderman; P F Pilch
Journal:  Endocrinology       Date:  1992-10       Impact factor: 4.736

3.  Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man.

Authors:  L I Koranyi; R E Bourey; H Vuorinen-Markkola; V A Koivisto; M Mueckler; M A Permutt; H Yki-Järvinen
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

4.  Training cessation does not alter GLUT-4 protein levels in human skeletal muscle.

Authors:  J A Houmard; T Hortobágyi; P D Neufer; R A Johns; D D Fraser; R G Israel; G L Dohm
Journal:  J Appl Physiol (1985)       Date:  1993-02

5.  Regulation of mitochondrial biogenesis in skeletal muscle by CaMK.

Authors:  Hai Wu; Shane B Kanatous; Frederick A Thurmond; Teresa Gallardo; Eiji Isotani; Rhonda Bassel-Duby; R Sanders Williams
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

6.  Expression and regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice.

Authors:  M L Liu; A L Olson; W S Moye-Rowley; J B Buse; G I Bell; J E Pessin
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

7.  Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene.

Authors:  J L Treadway; D M Hargrove; N A Nardone; R K McPherson; J F Russo; A J Milici; H A Stukenbrok; E M Gibbs; R W Stevenson; J E Pessin
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

8.  Myocyte enhancer factor 2 (MEF2) binding site is essential for C2C12 myotube-specific expression of the rat GLUT4/muscle-adipose facilitative glucose transporter gene.

Authors:  M L Liu; A L Olson; N P Edgington; W S Moye-Rowley; J E Pessin
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

9.  Effects of muscle activity and fiber composition on glucose transport and GLUT-4.

Authors:  L A Megeney; P D Neufer; G L Dohm; M H Tan; C A Blewett; G C Elder; A Bonen
Journal:  Am J Physiol       Date:  1993-04

10.  Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice.

Authors:  J M Ren; B A Marshall; M M Mueckler; M McCaleb; J M Amatruda; G I Shulman
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

View more
  3 in total

1.  Key Glycolytic Metabolites in Paralyzed Skeletal Muscle Are Altered Seven Days after Spinal Cord Injury in Mice.

Authors:  Zachary A Graham; Jacob A Siedlik; Lauren Harlow; Karim Sahbani; William A Bauman; Hesham A Tawfeek; Christopher P Cardozo
Journal:  J Neurotrauma       Date:  2019-04-10       Impact factor: 5.269

2.  Compensatory responses of the insulin signaling pathway restore muscle glucose uptake following long-term denervation.

Authors:  Zachary J Callahan; Michael Oxendine; Joshua L Wheatley; Chelsea Menke; Emily A Cassell; Amanda Bartos; Paige C Geiger; Paul J Schaeffer
Journal:  Physiol Rep       Date:  2015-04

3.  Impairments in site-specific AS160 phosphorylation and effects of exercise training.

Authors:  Leslie A Consitt; Jessica Van Meter; Christopher A Newton; David N Collier; Moahad S Dar; Jørgen F P Wojtaszewski; Jonas T Treebak; Charles J Tanner; Joseph A Houmard
Journal:  Diabetes       Date:  2013-06-25       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.